The Full ASGCT 27th Annual Meeting Abstracts Collection is NOW LIVE! Click here to read the full collection.
ASGCT and Pfizer grant supports independent medical education for rare disease cell and gene therapies.
ASGCT and Pfizer Global Medical Grants collaborated to offer a competitive grant opportunity focused on supporting medical education to increase the medical and scientific understanding of gene and gene-modified cell therapies.
Through Jan. 30, 2023, organizations submitted RFPs for independent initiatives that could result in measurable improvement in the understanding of therapies spanning multiple rare disease areas. They tailored their projects to members of multidisciplinary care teams for gene and gene-modified cell therapies, including pharmacists, specialty nurses, genetic counselors, medical geneticists, and other physicians.
Fondation Maladies Rares—Magda Granata, PhD Development of a Massive Open Online Training on Gene and Gene-modified Cell Therapies for Rare Diseases
Johns Hopkins University—Todd Dorman, MD Exploring the Gene Therapy Frontier: From Bench to Bedside
COR2ED—Antoine Lacombe, PharmD MDT Navigation of the Unique Challenges of Gene Therapy in Rare Diseases
Pontificia Universidad Javeriana—Carlos Javier Alméciga-Díaz, PhD Gene and Gene-Modified Cell Therapies Medical Education Program for Colombia and Other Latin American Countries
Academy of Managed Care Pharmacy—Jennifer Evans, PharmD AMCP eLD2023 / Managed Care and Health System Collaboration to Deliver Value and Equitable Access to Gene and Cell Therapy for Rare Diseases
May 7-11, 2024 | Baltimore, MD
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico